The molecular mechanisms of angiogenesis: A new approach to cardiovascular diseases

Italian Heart Journal

Volumn 2, Issue 2, 2001, Pages 81-92

  Brizzi, M F ^a   Formato, L ^a   Bonamini, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Angiogenesis; Arteriogenesis; Atherosclerosis

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 5; FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; NEUROPILIN; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SCATTER FACTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEALING; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; MEDICAL DOCUMENTATION; MOLECULAR BIOLOGY; ONTOGENY; REGULATORY MECHANISM; STIMULUS;

CARDIOVASCULAR DISEASES; COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035048353     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Coronary circulation
2. Tumor angiogenesis: Therapeutic implications
3. The growth of malignant disease in man and the lower animals with special reference to the vascular system
4. Mechanisms of angiogenesis
5. Vascular development: Cellular and molecular regulation
6. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
7. Arteriogenesis, the good and bad of it
8. The pathophysiology of the collateral circulation (arteriogenesis)
9. Endothelial receptor tyrosine kinases involved in angiogenesis
10. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
11. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretiontrap expression cloning
12. Angiopoietin-2, a natural antagonist for tie-2 that disrupts in vivo angiogenesis
13. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor during embryonic angiogenesis
14. Blood vessel formation: What is the molecular basis?
15. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase
16. Cardiovascular development: Prospects for a genetic approach
17. Isolation of putative progenitor endothelial cells for angiogenesis
18. Blood vessel maturation: Vascular development comes of age
19. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
20. Tumor necrosis factor inhibits the proliferation cultured capillary endothelial cells
21. High affinity immunoreactive FGF receptors in the matrix of vascular endothelial cells-implications for the modulation of FGF-2
22. Proteolytic balance and capillary morphogenesis
23. Matrix metalloproteinases
24. Human IL-3 stimulates endothelial cell mobility and promotes in vivo new vessel formation
25. Interleukin-6 stimulates motility of vascular endothelium
26. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokine in human aortic aneurysmal blood vessel growth
27. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism
28. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
29. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: Evidence of autocrine pathway of platelet-derived growth factor
30. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo
31. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin
32. Recent developments in the cell biology of basic fibroblast growth factor
33. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism
34. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix
35. Influence of the angiotensin system on endothelial and smooth muscle cell migration
36. Inhibition of angiogenesis by tissue inhibitor of metalloproteinases
37. High-density lipoprotein stimulates endothelial cell movements by a mechanism distinct from basic fibroblast growth factor
38. Approaches to studying cell adhesion molecules in angiogenesis
39. A novel role for E- and P-selectins: Shape of endothelial cell monolayers
40. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
41. Cell adhesion and angiogenesis
42. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis
43. Requirement of vascular integrin alpha V beta 3 for angiogenesis
44. Cell turnover of capillaries
45. Angiogenesis in human coronary atherosclerotic plaques
46. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
47. Role of the pericyte in wound healing. An ultrastructural study
48. Collateral circulation of the heart
49. Tractatus de Corde item de Motu & Colore Sanguinis et Chyli in eum Transitu
50. Molecular mechanisms of coronary collateral vessel growth
51. The collateral circulation of the heart
52. The collateral circulation in the human fetus: Angiographic findings
53. Intracoronary anastomosis in the absence of obstructive lesions of the coronary arteries
54. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion
55. VEGF, an important angiogenic factor is not involved in arteriogenesis
56. Vascular remodeling and altered protein expression during growth of coronary collateral arteries
57. Vascular endothelial growth factor (VEGF) and its receptors
58. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
59. Role of Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
60. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice
61. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
62. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
63. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
64. Receptors for factor of the VEGF family
65. In vivo angiogenic activity and hypoxia induction of heterodimers of placental growth factor/vascular endothelial growth factor
66. IL-3 stimulates migration and proliferation of vascular smooth muscle cells: A potential role in atherogenesis
67. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor
68. Neuropilin is a receptor for the axonal chemorepellent semaphorin III receptor
69. Neuropilin is a semaphorin III receptor
70. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice
71. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
72. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
73. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells-identification of a 5' enhancer
74. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
75. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds
76. Macrophage-dependent regulation of syndecans gene expression
77. PR39, a peptide regulator of angiogenesis
78. Increased gene expression for VEGF and the VEGF receptor KDR/Flk and Flt in lungs exposed to acute or chronic hypoxia
79. Functional up-regulation of the vascular endothelial growth factor receptor KDR by hypoxia
80. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling
81. Growth factor delivery strategies
82. Hypotensive activity of fibroblast growth factor
83. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
84. Collateral vessel growth in the human heart. Role of fibroblast growth factor-2
85. Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis
86. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner
87. Generation and localization of monoclonal antibodies against fibroblast growth factors in ischaemic collateralised porcine myocardium
88. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction
89. Atherosclerosis - An inflammatory disease
90. Intimal vascularization and atherosclerosis
91. Endoarteritis and arteritis
92. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis
93. Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombosis
94. Vasa vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis
95. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
96. Angiogenic activity of the atherosclerotic carotid artery plaque
97. The pathogenesis of coronary artery disease and the acute coronary syndromes (1)
98. Expression of the angiogenic protein, platelet-derived endothelial cell growth factor, in coronary atherosclerotic plaques: In vivo correlation of lesional microvessel density and constrictive vascular remodeling
99. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: A clue to the mechanism of transformation from the stable to the unstable clinical state
100. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty
101. Histopathologic features in atherectomy samples obtained from a patient with unstable angina, stable angina and restenosis: Directional Atherectomy Lombardi Group
102. Vascular endothelial cell growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries
103. Clinical trials in coronary angiogenesis: Issues, problems, consensus- An expert panel summary
104. A novel heart derived inhibitor of vascular cell proliferation. Purification and biological activity